Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury

Journal of Clinical Investigation

Volumn 106, Issue 2, 2000, Pages 225-234

  Terzi, Fabiola ^a   Burtin, Martine ^a   Hekmati, Mehrak ^a   Federici, Pierre ^b   Grimber, Giselle ^b   Briand, Pascale ^b   Friedlander, Gérard ^a  

^a INSERM   (France)

^b INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHOSPHORYLATION; DISEASE ASSOCIATION; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0033942485     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8315     Document Type: Article

References (57)

1. Wolf, G., and Neilson, E.G. 1991. Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int. 39:401-420.
2. Hamm, L.L., Hering, S.K., and Vehaskari, V.M. 1993. Epidermal growth factor and the kidney. Semin. Nephrol. 13:109-115.
3. Moghal, N., and Sternberg, P.W. 1999. Multiple positive and negative regulators of signaling by the EGF-recepror. Curr. Opin. Cell. Biol. 11:190-196.
4. Salido, E.C., Lakshmanan, J., Fisher, D.A., Shapiro, L.J., and Barajas, L. 1991. Expression of epidermal growth factor in the rat kidney. An immunocytochemical and in situ hybridization study. Histochemistry. 96:65-72.
5. Breyer, M.D., Redha, R., and Breyer, J.A. 1990. Segmental distribution of epidermal growth factor binding sites in rabbit nephron. Am. J. Physiol. 259:F553-F558.
6. Norman, J., et al. 1987. EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. Am. J. Physiol. 253:F299-F309.
7. Goodyer, P.R., Kachra, Z., Bell, C., and Rozen, R. 1988. Renal tubular cells are potential targets for epidermal growth factor. Am. J. Physiol. 255:F1191-F1196.
8. Sponsel, H.T., Breckon, R., Hammond, W., and Anderson, R.J. 1994. Mechanisms of recovery from mechanical injury of renal tubular epithelial cells. Am. J. Physiol. 267:F257-F264.
9. Kjelsberg, C., et al. 1997. Met-/-kidneys express epithelial cells that chemotax and form tubules in response to EGF receptor ligands Am. J. Physiol. 272:F222-F228.
10. Creely, J.J., DiMari, S.J., Howe, A.M., Hyde, C.P., and Haralson, M.A. 1990. Effects of epidermal growth factor on collagen synthesis by an epithelioid cell line derived from normal rat kidney. Am. J. Pathol. 136:1247-1257.
11. Taub, M., Wang, Y., Szczesny, T.M., and Kleinman. H.K. 1990. Epidermal growth factor or transforming growth factor alpha is required for kidney tubulogenesis in matrigel cultures in serum-free medium. Proc. Natl. Acad Sci. USA. 87:4002-4006.
12. Humes, H.D., Cieslinski, D.A., Coimbra, T.M., Messana, J.M., and Galvao, C. 1989. Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J. Clin. Invest. 84:1757-1761.
13. Coimbra, T.M., Cieslinski, D.A., and Humes, H.D. 1990. Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am. J. Physiol. 259:F438-F443.
14. Jennische, E., Andersson, G., and Hansson, H.A. 1987. Epidermal growth factor is expressed by cells in the distal tubules during postnephrectomy renal growth. Acta Physiol. Scand. 129:449-450.
15. Kanda, S., et al. 1991. Transient increase in renal epidermal growth factor content after unilateral nephrectomy in the mouse. Acta. Endocrinol. 124:188-193.
16. Miller, S.B., Rogers, S.A., Estes, C.E., and Hammerman, M.R. 1992. Increased distal nephron EGF content and altered distribution of peptide in compensatory renal hypertrophy. Am. J. Physiol. 262:F1032-F1038.
17. Muchaneta-Kubara, E.C., Sayed-Ahmed, N., and el Nahas, A.M. 1995. Subtotal nephrectomy: a mosaic of growth factors. Nephrol. Dial. Transplant. 10:320-327.
18. Terzi, F., Burtin, M. and Friedlander, G. 1998. Early molecular mechanisms in the progression of renal failure: role of growth factors and protooncogenes. Kidney Int. Suppl. 53:S68-S73.
19. Wilson, P.D., Du, J., and Norman, J.T. 1993. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease. Eur. J.Cell Biol. 61:131-138.
20. Orellana, S.A., Sweeney, W.E., Neff, C.D., and Avner, E.D. 1995. Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int. 47:490-499.
21. Uhlman, D.L., et al. 1995. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis. Clin. Cancer Res. 1:913-920.
22. Lowden, D.A., et al. 1994. Renal cysts in transgenic mice expressing transforming growth factor-alpha. J. Lab. Clin Med. 124:386-394.
23. Stocklin, E., Botteri, F., and Groner, B. 1993. An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice. J.Cell Biol. 122:199-208.
24. Schaffner, D. L., et al. 1993. Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am. J. Pathol. 142: 1051-1060.
25. Richards, W.G., et al. 1998. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J. Clin. Invest. 101:935-939.
26. Prewett, M., et al. 1998. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice. Clin. Cancer Res. 4:2957-2966.
27. Miettinen, P.J., et al. 1995. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 376:337-341.
28. Sibilia, M., and Wagner, E.F. 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:234-238.
29. Threadgill, D.W., et al. 1995. Targeted disruption of mouse FGF receptor: effect of genetic background on mutant phenotype. Science. 269:230-234.
30. Luetteke, N.C., et al. 1994. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8:399-413.
31. Jacquemin, E., et al. 1990. Pattern of expression of gamma-glutamyl transpepridase in rat liver and kidney during development: study by immunochemistry and in situ hybridisation. J. Pediatr. Gastroentirol. Nutr. 11:89-95.
32. Terzi, F., et al. 1997. Reduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide balance. J. Clin. Invest. 100:1520-1528.
33. Terzi, F., Beaufils, H., Laouari, D., Burtin, M., and Kleinknecht, C. 1992 Renal effect of anti-hypertensive drugs depends on sodium diet in the excision remnant kidney model. Kidney Int. 42:354-363.
34. Terzi, E., et al. 1997. Normal tubular regeneration and differentiation of the post-ischemic kidney in mice lacking vimentin. Am. J. Pathol. 150:1361-1373.
35. Iimura, O., Wrtovsnik, F., Terzi, F. and Friedlander, G. 1997. HMG-CoA reducrase inhibitors induce apoptosis in mouse proximal tubular cells in primary culture. Kidney Int. 52:962-972.
36. Raij, L., Azar, S., and Keane, W. 1984. Mesangial immune injury. hypertension and progressive glomerular damage in Dahl rats. Kidney Int. 26:137-143.
37. Laouari, D., et al. 1997. Subtotal nephrectomy alters tubular function: effect of phosphorus restriction. Kidney Int. 52:1550-1560.
38. Livneh, H., et al. 1986. Reconstitution of human epidermal growth factor receptors and its deletion mutanrs in cultured hamster cells. J. Biol. Chem. 261:12490-12497.
39. Harris, R.C. 1991. Potential physiologic roles for epidermal growth factor in the kidney. Am. J. Kidney Dis. 17:627-630.
40. Terzi, E., et al. 2000 Sodium restriction decreases AP-1 activation after nephron reduction in the rat: role in the progression of renal lesions. Exp. Nephrol. 8:104-114.
41. Terzi, F., et al. 1995. Subtotal but not unilateral nephrectomy induces hyperplasia and protooncogene expression. Am. J. Physiol. 268:F793-F801.
42. Kashles, O., Yarden, Y., Fischer, R., Ullrich, A., and Schlessinger, J. 1991. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol. Cell. Biol. 11:1454-1463.
43. Redemann, N., et al. 1592. Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants. mol. Cell Biol. 12:491-498.
44. Murillas, R., et al. 1995. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J. 14:5216-3223.
45. Harris, R.C. 1991. Potential physiologic roles for epidermal growth factor in the kidney. Am. J. Kidney Dis. 17:627-630.
46. Moyer, J.H., et al. 1994. Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science. 264:1329-1333.
47. Morrison, A.B. 1962. Experimentally induced chronic renal insufficiency in the rat. Lab. Invest. 11:321-332.
48. Shimamura, T., and Morrison, A.B. 1975. A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am. J. Pathol. 79:95-106.
49. Esposito, C., He, C.J., Striker, G.E., Zalups, R.K., and Striker, L.J. 1999. Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Am. J. Pathol. 154:891-897.
50. Kren, S., and Hostetter, T.H. 1999. The course of the remnant kidney model in mice. Kidney Int. 56:333-337.
51. Korthagen, T.R., et al. 1994. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J. Clin. Invest. 93:1691-1699.
52. Hardie, W.D., et al. 1996. Reversal of lung lesions in transgenic transforming growth factor alpha mice by expression of mutant epidermal growth factor receptor. Am. J. Respir. Cell Mol. Biol. 15:499-508.
53. Strutz, E., et al. 1995. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 130:393-405.
54. Okada, H., Danoff, T.M., Kalluri, R., and Neilson, E.G. 1997. Early role of Esp1 in epithelial-mesenchymal transformation Am. J. Physiol. 273:F563-574.
55. 1-independent mechanism. Kidney Int. 52:637-647.
56. Schena, F.P., Gesualdo, L., Grandaliano, G., and Montinaro, V. 1997. Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? Kidney Int. 52:1439-1457.
57. Malyankar, U.M., Almeida, M., Johnson, R.J., Pichler, R.H., and Grachelli, C.M. 1997. Osteopontin regulation in cultured rat renal epithelial cells. Kidney Int. 51:1766-1773.